TASK vs VRTX
Taskus Inc (TASK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
TASK currently screens at market cap $492.7M and trailing P/E 4.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the TASK and VRTX stock pages for the full models.
Not investment advice.